Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
251.18B
Market cap251.18B
Price-Earnings ratio
26.70
Price-Earnings ratio26.70
Dividend yield
2.16%
Dividend yield2.16%
Average volume
2.99M
Average volume2.99M
High today
$467.01
High today$467.01
Low today
$454.63
Low today$454.63
Open price
$465.14
Open price$465.14
Volume
823.13K
Volume823.13K
52 Week high
$483.99
52 Week high$483.99
52 Week low
$312.39
52 Week low$312.39

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $464.36. The company's market cap stands at 251.18B, with a P/E ratio of 26.70 and a dividend yield of 2.16%.

On 2026-11-09, Amgen(AMGN) stock moved within a range of $454.63 to $467.01. With shares now at $464.36, the stock is trading +2.1% above its intraday low and -0.6% below the session's peak.

Trading activity shows a volume of 823.13K, compared to an average daily volume of 2.99M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

AMGN News

Simply Wall St 24m
Is Amgen Expensive On Strong Q3 Results And Pipeline Progress?

Amgen (AMGN) has been in focus after a packed early November. Fresh third quarter figures, new real world Repatha data and progress in obesity and autoimmune pr...

Is Amgen Expensive On Strong Q3 Results And Pipeline Progress?
The Motley Fool 21h
The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation

Biotech stocks have performed well in 2026, but things could change fairly rapidly. The industry is notoriously volatile, after all, and there are significant r...

The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation
24/7 Wall St. 1d
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today - 24/7 Wall St.

...

Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today - 24/7 Wall St.

Analyst ratings

54%

of 37 ratings
Buy
29.7%
Hold
54.1%
Sell
16.2%

More AMGN News

Simply Wall St 1d
How Investors May Respond To Amgen Earnings Beat

Amgen reported third quarter 2026 revenue of US$10.365b and net income of US$3.864b, alongside fresh real world data showing Repatha cut heart attack risk by 20...

How Investors May Respond To Amgen Earnings Beat
Simply Wall St 2d
Amgen Stock Could Be 34% Below Fair Value Following Raised Guidance

has been a strong performer in large-cap biotech, and with the stock recently around US$460 per share the key question for you is how well that price lines up w...

Amgen Stock Could Be 34% Below Fair Value Following Raised Guidance
The Motley Fool 4d
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Can a growth-oriented biotech giant outpace a value-leaning pharmaceutical titan? Choosing between Amgen Inc. (AMGN -0.79%) and Pfizer Inc. (PFE +0.93%) require...

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?
Investor's Business Daily 4d
Cardinal Health Deepens Its Grip On The Buy Zone On Street-Beating Guidance

Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results 10/27/2026 Dow Jones biotech giant Amgen stock is trying to break out past a new buy poin...

Cardinal Health Deepens Its Grip On The Buy Zone On Street-Beating Guidance
TipRanks 5d
Amgen Earnings Call Highlights Growth, Pipeline Momentum

Amgen Inc ((AMGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Amgen’s third-quarter call carried a strongly optimistic tone, w...

Benzinga 5d
Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data

Amgen Inc. (NASDAQ:AMGN) shares are trading close to its 52-week high on Wednesday after the company reported better-than-expected third-quarter financial resul...

Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
Zacks 5d
AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance

Amgen (AMGN Quick QuoteAMGN - Free Report) reported third-quarter 2026 adjusted earnings of $6.45 per share, up 14% year over year, driven primarily by hi...

AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.